Related Experiment Video
Updated: Jul 31, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Update on the management of glaucoma.
Summary
Glaucoma treatment progresses from medication to laser therapy, then surgery. Ultrasound offers a novel option for refractory glaucoma, while acute cases require immediate intervention. Medication side effects are also reviewed.
Area of Science:
- Ophthalmology
- Glaucoma Management
- Medical Interventions
Background:
- Glaucoma management typically involves medical therapy, laser trabeculoplasty, and surgical interventions.
- Refractory glaucoma cases pose challenges when standard treatments are ineffective.
- Acute angle-closure glaucoma is an ophthalmic emergency requiring prompt treatment.
Purpose of the Study:
- To review current and novel treatment modalities for glaucoma.
- To discuss the management of both chronic open-angle and acute angle-closure glaucoma.
- To highlight the potential of ultrasound in refractory glaucoma cases.
Main Methods:
- Review of medical treatments including carbonic anhydrase inhibitors, beta blockers, parasympathomimetics, and sympathomimetics.
- Discussion of laser trabeculoplasty and surgical options for glaucoma.
- Exploration of ultrasound as a treatment for refractory glaucoma.
- Analysis of potential severe and fatal side effects of glaucoma medications.
Main Results:
- Medical management is the primary treatment for most chronic open-angle glaucoma.
- Laser trabeculoplasty and surgery are subsequent steps when medical treatment fails.
- Ultrasound has shown success in controlling glaucoma unresponsive to conventional therapies.
- Peripheral iridectomy is crucial for early treatment of acute angle-closure glaucoma.
Conclusions:
- A stepwise approach is standard for chronic open-angle glaucoma, with ultrasound as a promising alternative for resistant cases.
- Prompt intervention is critical for acute angle-closure glaucoma.
- Understanding and managing medication side effects is essential for patient safety in glaucoma treatment.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...